Jim Simons Fennec Pharmaceuticals Inc. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.82 - $11.12 $1.23 Million - $1.56 Million	139,900 New	139,900 $1.56 Million
Q3 2021 Nov 12, 2021	SELL	$6.51 - $9.62 $132,048 - $195,132	-20,284 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.96 - $7.85 $120,892 - $159,229	20,284 New	20,284 $148,000
Q3 2020 Nov 13, 2020	SELL	$5.19 - $10.17 $695,460 - $1.36 Million	-134,000 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$5.43 - $9.39 $314,418 - $543,718	57,904 Added 76.09%	134,000 $1.12 Million
Q1 2020 May 14, 2020	BUY	$4.89 - $8.1 $255,727 - $423,597	52,296 Added 219.73%	76,096 $452,000
Q4 2019 Feb 13, 2020	BUY	$4.25 - $6.49 $101,150 - $154,462	23,800 New	23,800 $154,000
Q2 2019 Aug 12, 2019	SELL	$3.3 - $5.09 $102,630 - $158,299	-31,100 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$4.64 - $7.58 $144,304 - $235,738	31,100 New	31,100 $151,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $104M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.